Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Dermatology|May 3, 2023
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasisHidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, et al.
The Journal of Dermatology|October 8, 2020
Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 resultsAkimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, et al.
The Journal of Dermatology|December 30, 2022
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, et al.
Dermatology and Therapy|June 19, 2024
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled StudyYukari Okubo, Tadashi Terui, Satomi Kobayashi, et al.
The Journal of Dermatology|January 6, 2021
Dietary habits in Japanese patients with palmoplantar pustulosisNaotaka Serizawa, Shizuka Okazaki, Yohei Otsuka, et al.
American Journal of Clinical Dermatology|May 26, 2023
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled StudyTadashi Terui, Yukari Okubo, Satomi Kobayashi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2025
Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trialTadashi Terui, Yukari Okubo, Satomi Kobayashi, et al.
Lancet (London, England)|February 7, 2021
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trialKristian Reich, Kim A Papp, Andrew Blauvelt, et al.
Dermatology and Therapy|December 12, 2025
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 TrialTadashi Terui, Yukari Okubo, Satomi Kobayashi, et al.
The Journal of Dermatology|August 4, 2017
Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologicsTakuro Kanekura, Mariko Seishima, Masaru Honma, et al.
Pageof 12